Evaluation of T-cell immunoglobulin mucin 3 (TIM3) as ahighly sensitive minimal residual disease (MRD) monitoring strategy to predict relapse after Bone Marrow Transplant
Mohamed Saad Mohamed Ahmed El safty;
Abstract
Disease recurrence is a devastating event after allogeneic hematopoietic stem cell transplantation as treatment for acute leukemia. Median time to relapse is approximately 4 months and the majority of relapses occur within 2 years after transplant. The prognosis is usually poor. Overall 5-year survival of all patients relapsing post-transplant for acute leukemia
Evaluation of TIM-3 level is highly monitoring strategy used as minimal residual disease to predict relapse post bone marrow transplant.
TIM-3 level post BMT has significant relation with over-all survival and disease free survival in cases of acute leukemia post allograft
Evaluation of TIM-3 level is highly monitoring strategy used as minimal residual disease to predict relapse post bone marrow transplant.
TIM-3 level post BMT has significant relation with over-all survival and disease free survival in cases of acute leukemia post allograft
Other data
| Title | Evaluation of T-cell immunoglobulin mucin 3 (TIM3) as ahighly sensitive minimal residual disease (MRD) monitoring strategy to predict relapse after Bone Marrow Transplant | Other Titles | دلالة تقييم الخلية المناعية المخاطية تي3 واستخدامها كمقياس للحد الادني المتبقي للمرض كمؤشر لحدوث انتكاسة مابعد عملية زرع النخاع العظمي | Authors | Mohamed Saad Mohamed Ahmed El safty | Issue Date | 2020 |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| BB7199.pdf | 1.57 MB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.